Evidence map›Paper›PMID 36709106›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022

[Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma].

Y F Shi, Z F Gao, X H Li, L G Guo, Q L Zheng, M P Long, L J Deng, T T Du, L Jia, W Zhao and 2 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Y F ShiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education) , Department of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Z F GaoDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China Department of Pathology, Beijing Boren Hospital, Beijing 100070, China.
X H LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education) , Department of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
L G GuoDepartment of Pathology, Beijing Boren Hospital, Beijing 100070, China.
Q L ZhengMedical Laboratory of Molecular Diagnostic Laboratory, Beijing Boren Hospital Department, Beijing 100070, China.
M P LongKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education) , Department of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
L J DengKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.
T T DuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China.
L JiaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education) , Department of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
W ZhaoClinical Laboratory Center, Capital Medical University, Beijing 100069, China.
X X SongDepartment of Pathology, Hebei Eye Hospital, Shijiazhuang 054001, China.
M LiDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Large B-Cell, DiffuseTumor Suppressor Protein p53East Asian PeopleHumansMutationPrognosisTumor Suppressor Protein p53ImmunohistochemistryLymphoma, large b-cell, diffuseMutationPrognosisTumor Suppressor Protein p53

Identifiers

PMID36709106
PMCPMC9939333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.